Amgen (AMGN) EBT (2009 - 2026)

Amgen (AMGN) has reported EBT for 18 consecutive years, with $2.1 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, EBT rose 5.63% year-over-year to $2.1 billion; the TTM figure through Mar 2026 stood at $9.1 billion (up 36.65% YoY), while the FY2025 annual figure was $9.0 billion, up 94.75% from the prior year.
• EBT came in at $2.1 billion for Q1 2026 at Amgen, up from $1.5 billion in the prior quarter.
• The five-year high for EBT was $3.9 billion in Q3 2025, with the low at -$68.0 million in Q1 2024.
• Average EBT over 5 years is $1.8 billion, with a median of $1.7 billion recorded in 2022.
• Across the five-year window, EBT slumped 101.98% in 2024 and surged 3001.47% in 2025, its largest moves.
• Year by year, EBT stood at $1.7 billion in 2022, then sank by 51.26% to $852.0 million in 2023, then fell by 8.22% to $782.0 million in 2024, then soared by 93.61% to $1.5 billion in 2025, then soared by 37.65% to $2.1 billion in 2026.
• According to Business Quant data, EBT over the past three periods registered $2.1 billion, $1.5 billion, and $3.9 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.